Lion Biotechnologies, Inc. 4
4 · Lion Biotechnologies, Inc. · Filed Jan 29, 2015
Insider Transaction Report
Form 4
Hillsberg Sanford
Director
Transactions
- Other
Warrant
2015-01-28−25,000→ 0 total(indirect: By Trust)Exercise: $2.50From: 2013-11-05Exp: 2018-11-05→ Common Stock (25,000 underlying) - Other
Common Stock
2015-01-28−25,000→ 0 total(indirect: By Trust) - Award
Common Stock
2014-12-16+25,000→ 25,000 total(indirect: By Trust) - Award
Warrant
2014-12-16+25,000→ 25,000 total(indirect: By Trust)Exercise: $2.50From: 2013-11-05Exp: 2018-11-05→ Common Stock (25,000 underlying)
Holdings
- 269,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]These securities were acquired by Herbert Hillsberg in 2013. Following Herbert Hillsberg's death, the securities were transferred from the Estate of Herbert Hillsberg into the Herbert Hillsberg Revocable Trust on December 16, 2014. Sanford J. Hillsberg is one of four trustees of the Herbert Hillsberg Trust. However, as a contingent beneficiary, Sanford Hillsberg had no right to receive these securities or their proceeds, but depending upon the order of family survivorship and residual proceeds, could be entitled in the future to receive up to 33-1/3% of these securities or proceeds. The reporting person disclaims beneficial ownership of the securities held by the Herbert Hillsberg Revocable Trust except to the extent of his contingent pecuniary interest in these securities.
- [F2]These securities were acquired by Herbert Hillsberg in an offering by the Issuer of common stock and warrants whereby a purchase of each share of common stock included a warrant exercisable for one share of common stock at $2.50 per share.
- [F3]On January 28, 2015, the four trustees of the Herbert Hillsberg Revocable Trust caused the trust to distribute all of these securities to Herbert Hillsberg's widow.